Clinigen Acquires Oncology Support Therapy Cardioxane® From Novartis AG (NVS)
3/26/2013 11:23:12 AM
More...
|
Clinigen and Theravance, Inc. (THRX) Announce Exclusive Commercialization Agreement in the EU for VIBATIV® (telavancin)
3/11/2013 9:38:37 AM
More...
|
Clinigen Raises £50 Million as it Prepares to Float
9/20/2012 7:48:34 AM
More...
|
Clinigen Signs EU-wide Clinical Trial Distribution Agreement for Accord Healthcare's Injectable Oncology Drugs Portfolio
6/20/2012 12:49:38 PM
More...
|
Clinigen Appointed by BTG plc (BGC.L) to Manage Named-Patient Programs for DigiFab(r) and Voraxaze(r) in Certain Territories Outside the US
6/1/2012 11:14:21 AM
More...
|
Clinigen Gains FDA Approval for Foscavir in HIV/AIDS-related Cytomegalovirus Infections and Herpes
5/8/2012 7:01:17 AM
More...
|